By Nigam Arora & Dr. Natasha Arora

39.5% Profit In One Day

The Arora Report gave a signal to buy biotech MorphoSys AG (MOR). The signal stated that MorphoSys was likely to be bought out and result in hefty gains for investors.
Only a day later, a major, multinational, biopharma company Novartis (NVS) agreed to buyout MorphoSys. The result is 39.5% profit in one day to the buyout price.

The Chart

Note the following:
  • The chart shows when Arora buy signal was given.
  • The signal indicated that MorphoSys had become a buyout target.
  • To control risk, the signal also provided a stop loss and recommended quantity.
  • The signal also provided a target zone.
  • The chart shows the move up on the buyout.

Opportunities In Cancer Cures

The reason Novartis was willing to pay such a high price for MorphoSys was MorphoSys’s drug that is under development called pelabresib. Pelabresib may be a game changer in myelofibrosis and knotty lymphomas.

Lucrative Space

Curing cancer has become a lucrative space for big pharma. Big pharma is hunting for smaller biotechs with promising drugs. When these biotechs get bought out, they produce huge profits for investors.

Unrivaled Record

The Arora Report specializes in finding companies that get bought out. To date, 190 Arora Report portfolio companies have been bought out, producing a fortune for long time members of The Arora Report. This performance is better than firms charging upwards of $50,000 per year. With The Arora Report, you get so much more.


The Arora Report gives you a variety of opportunities. We just illustrated the opportunity with a cancer drug biotech. Here are other examples of successful Arora signals:
  • Iconic American steel company
  • A natural gas producer
  • Software company producing simulation software
  • Retailer of luxury handbags
  • Infrastructure software company
  • Entertain and sports company
  • A defense company
  • Aluminum fabricator
  • A biotech producing treatments for psoriasis
  • A biotech finding cures for rare and rheumatic diseases
  • A company providing value based healthcare

You Too Can Make A Fortune

You too can make a fortune just like thousands of your fellow investors.  The time to start is now!  You can start today by taking a free trial to ZYX Buy Change Alert.  Your satisfaction is 100% guaranteed.  Your credit card is not charged during the 30-day trial.  Please click here to start your trial.

This post was just published on ZYX Buy Change Alert.

Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE

Please click here to take advantage of a FREE 30 day trial.

Picture of Nigam Arora

Nigam Arora

Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.

Picture of Dr. Natasha Arora

Dr. Natasha Arora

Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.

Subscribe to 'Generate Wealth'

Free Forever

More To Explore

30 Day Free Trial

Cancel within 30 days and you owe nothing

When you take a FREE 30 day trial, you get access to powerful techniques used by billionaires and hedge funds to grow richer. You can continue to use these powerful techniques to grow richer even if you cancel your subscription. You come out ahead by subscribing no matter how you look at it.

A fortune is to be made from AI stocks.
Get the list of 18 AI stocks to grab your share of the profits — no cost to you.

A fortune is to be made from AI stocks.

Get the list of 18 AI stocks to grab your share of the profits.

AI is a $1 Trillion Market

Making A Fortune
In Artificial Intelligence

Golden Age of Artificial Intelligence

Skip to content